( MENAFN - EIN Presswire) PORTLAND, ID, UNITED STATES, October 28, 2024 /EINPresswire / -- Global Peritoneal Dialysis market was valued at $3,213 million in 2017, and is expected to reach $5,074 million by 2025, growing at a CAGR of 5.8% from 2018 to 2025. Factors such as increase in awareness about automated peritoneal dialysis, technological advancement in peritoneal dialysis cyclers, rise in prevalence of end stage renal disease (ESRD), and surge in demand for home dialysis treatment are expected to boost the growth of the peritoneal dialysis market during the forecast period.
In addition, peritoneal dialysis offers some advantages such as, low cost as compared to hemodialysis, needle free treatment, portability, treatment convenience, and few dietary restrictions, further drive the market growth globally. However, risk associated with peritoneal dialysis such as peritonitis, infection, weight gain, and hernia are expected to impede the market growth. Some of the key players involved in the Market are: Utah Medical Products, Inc, Newsol Technologies Inc, Baxter International Inc, Medtronic Plc, Cook Medical Inc, Fresenius Medical Care AG & Co.
KGaA, Renax Biomedical Tech. Co., Ltd, Medionics International, Inc, Terumo Corporation, Poly Medicure Ltd Download the Exclusive Sample Report @ The peritoneal dialysis market can be segmented based on various factors.
Here are some common segments used in the industry: Type of Peritoneal Dialysis: a. Continuous Ambulatory Peritonea.
